EVMT — Evome Medical Technologies Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Evome Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
R2020 February 29th | 2021 February 28th | 2022 February 28th | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 10 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.402 | 0.15 | 18.3 | 33.6 | 62.6 |
| Cost of Revenue | |||||
| Gross Profit | 0.384 | — | 5.96 | 10.6 | 22.5 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.75 | 2.82 | 28.3 | 39.1 | 82.3 |
| Operating Profit | -1.35 | -2.67 | -9.96 | -5.53 | -19.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.35 | -2.67 | -4.47 | -19 | -15.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.35 | -2.67 | -4.37 | -15.9 | -15.6 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.92 | -2.67 | -4.37 | -15.9 | -15.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.92 | -2.67 | -4.37 | -15.9 | -15.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.037 | -0.025 | 0.039 | -0.256 | -0.087 |
| Dividends per Share | |||||
| Special Dividends per Share |